Compositions and methods for treating surgical adhesions

Overview

Information

Number
6689803
Application
10/067467
Filing date
02/05/2002
Issue date
02/10/2004
Inventor(s)
William L. Hunter
US Classification
514/365
View at USPTO

Citations

Sanofi-aventis (10)
Bristol-Myers Squibb (5)
ALABAMA AT BIRMINGHAM, UNIVERSITY OF (5)
Poly-Med (4)
IPXMEDICAL, LLC (4)
Angiotech International (4)
Merrell Dow Pharmaceuticals (3)
Regents of the University of California, The (3)
NA (3)
The United States of America as represented by the Department of Health (2)
Children's Medical Center (2)
The Johns Hopkins University (2)
UNITED STATES OF AMERICA, THE, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (2)
Massachusetts Institute Of Technology (2)
Thomas Jefferson University (2)
Pfizer (2)
Eisai Co. (2)
McGill University (1)
AMO UPPSALA AB (1)
Rhone-Poulenc Rorer (1)
COVALON technology (1)
HOSTETLER FAMILY TRUST (1)
COOK MEDICAL TECHNOLOGIES (1)
Procter & Gamble (1)
Vestar (1)
HOSTETLER, KARL Y. (1)
ANGIODEVICE INTERNATIONAL (1)
Chimerix (1)
PG-TXL (1)
Chemex Pharmaceuticals (1)
Matrix Pharmaceutical (1)
Vertex Pharmaceuticals (1)
Regents Of The University of Minnesota (1)
Celgene (1)
Montana State University (1)
Hospira (1)
Advanced cardiovascular Systems (1)
Tapestry Pharmaceuticals (1)
Phanos Technologies (1)
SPEED GEL (1)

Abstract

Abstract

Methods and compositions for treating or preventing inflammatory diseases such as psoriasis or multiple sclerosis are provided, comprising the step of delivering to the site of inflammation an anti-microtubule agent, or analogue or derivative thereof.

Assignees with Similar Patents

Angiotech International (19)
PG-TXL (12)
IPXMEDICAL, LLC (8)
ANGIODEVICE INTERNATIONAL (5)
Samyang (5)

Referenced by

Boston Scientific (38)
broncus medical (15)
conextions (15)
CritiTech (14)
Celgene (12)
dfb soria (7)
University of Utah (5)
SurModics (4)
ROCHE DIAGNOSTICS HEMATOLOGY, INC. (2)
Covidien (2)
COOK MEDICAL TECHNOLOGIES (2)
SWEET, RICHARD M. (2)
Industrial Technology research Institute (2)
Broncus Technologies (2)
Cardiac Pacemakers (2)
Bristol-Myers Squibb (1)
UNIVERSITY OF BRITISH COLUMBIA, THE (1)
dfb soria ll (1)
University of Kentucky Research Foundation (1)
Otago Innovation (1)
Remon Medical Technologies (1)
Omeros (1)
critltech (1)
Abbott Laboratories (1)
resurge therapeutics (1)

Tech Analysis

Class Subclass Type Reference Factor Citation Factor Strength Grant time Early grant (%)
514 365 Emerging Sustaining Seminal Medium Average 40.7